Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0089
0.00 (0.00%)
Apr 27, 2026, 9:30 AM EST
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $624.68 thousand as of April 28, 2026. Its market cap has decreased by -73.92% in one year.
Market Cap
624.68K
Enterprise Value
31.06M
Revenue
12.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 624.68K, a decrease of -99.82%. That is a compound annual growth rate of -60.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 624.68K | -24.76% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halberd | 784.67K |
| Aibotics | 725.53K |
| Hepion Pharmaceuticals | 721.10K |
| SQZ Biotechnologies Company | 707.79K |
| Eloxx Pharmaceuticals | 608.63K |
| Regenerative Medical Technology Group | 525.56K |
| Bio-Path Holdings | 521.76K |
| Altamira Therapeutics | 513.82K |